GUAIFENESIN 400 MG

GUAIFENESIN 400 MG was reported 7622 times

GUAIFENESIN 400 MG is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 35 0.1155
1 DELUSION OF PARASITOSIS 6 0.0382
2 FEMALE GENITAL TRACT FISTULA 36 0.0211
3 REDUCED FACIAL EXPRESSION 20 0.0197
4 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 20 0.0188
5 OBLITERATIVE BRONCHIOLITIS 21 0.0160
6 RADICULOPATHY 37 0.0140
7 HYPERPARATHYROIDISM SECONDARY 35 0.0140
8 PROCTITIS 37 0.0132
9 BRONCHITIS CHRONIC 30 0.0123
10 CHRONIC SINUSITIS 45 0.0120
11 RHONCHI 16 0.0116
12 CONTRAST MEDIA ALLERGY 21 0.0115
13 OROPHARYNGEAL CANDIDIASIS 10 0.0110
14 NEPHROGENIC ANAEMIA 51 0.0110
15 CONDUCTION DISORDER 18 0.0098
16 PNEUMONIA RESPIRATORY SYNCYTIAL VIRAL 7 0.0083
17 CHRONIC RESPIRATORY FAILURE 10 0.0083
18 PNEUMONIA PSEUDOMONAL 12 0.0078
19 DILATATION ATRIAL 9 0.0077
20 ESSENTIAL HYPERTENSION 14 0.0076
21 SINUSITIS BACTERIAL 7 0.0066
22 LISTLESS 21 0.0064
23 BREATH SOUNDS ABNORMAL 31 0.0063
24 ACUTE SINUSITIS 10 0.0058
25 ECHOCARDIOGRAM ABNORMAL 8 0.0057
26 RENAL ATROPHY 7 0.0056
27 BRONCHIAL SECRETION RETENTION 7 0.0055
28 LOBAR PNEUMONIA 10 0.0054
29 ECONOMIC PROBLEM 80 0.0053
30 PRODUCT SIZE ISSUE 28 0.0052
31 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 7 0.0052
32 ISCHAEMIC HEPATITIS 7 0.0051
33 SPUTUM INCREASED 11 0.0051
34 CULTURE URINE POSITIVE 7 0.0050
35 RHINITIS ALLERGIC 22 0.0049
36 CONNECTIVE TISSUE DISORDER 7 0.0049
37 IMMOBILE 21 0.0048
38 PULMONARY VALVE INCOMPETENCE 7 0.0048
39 NODAL RHYTHM 7 0.0048
40 ORAL CANDIDIASIS 63 0.0048
41 REBOUND ACID HYPERSECRETION 14 0.0046
42 PARAINFLUENZAE VIRUS INFECTION 7 0.0046
43 OCCULT BLOOD POSITIVE 9 0.0046
44 FOREIGN BODY IN THROAT 14 0.0044
45 INFUSION SITE PRURITUS 14 0.0044
46 ORTHOPNOEA 14 0.0044
47 ACUTE RESPIRATORY FAILURE 84 0.0044
48 FOREIGN BODY 17 0.0042
49 ATELECTASIS 41 0.0042
50 CHEST X-RAY ABNORMAL 13 0.0042
51 END STAGE RENAL DISEASE 77 0.0042
52 RHINOVIRUS INFECTION 16 0.0041
53 PNEUMONIA STAPHYLOCOCCAL 8 0.0041
54 RALES 23 0.0040
55 PNEUMONIA KLEBSIELLA 7 0.0038
56 VAGINAL DISCHARGE 38 0.0038
57 PERIPHERAL VASCULAR DISORDER 19 0.0037
58 PRE-EXISTING CONDITION IMPROVED 23 0.0037
59 BENIGN PROSTATIC HYPERPLASIA 19 0.0037
60 CARDIOMEGALY 44 0.0036
61 BRAIN NATRIURETIC PEPTIDE INCREASED 11 0.0036
62 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 186 0.0036
63 COMPUTERISED TOMOGRAM ABNORMAL 8 0.0035
64 MACULAR DEGENERATION 42 0.0035
65 AORTIC ARTERIOSCLEROSIS 9 0.0035
66 PNEUMONIA VIRAL 11 0.0034
67 HYPERVOLAEMIA 17 0.0034
68 TRICUSPID VALVE INCOMPETENCE 27 0.0034
69 DILATATION VENTRICULAR 7 0.0033
70 OTITIS MEDIA 11 0.0033
71 PNEUMONIA BACTERIAL 30 0.0033
72 HYPERLIPIDAEMIA 39 0.0033
73 PLEURITIC PAIN 9 0.0033
74 CARDIAC MURMUR 28 0.0032
75 PSEUDOMONAS INFECTION 27 0.0031
76 SUPRAVENTRICULAR TACHYCARDIA 30 0.0031
77 BRONCHIECTASIS 21 0.0031
78 LUMBAR SPINAL STENOSIS 9 0.0031
79 DECUBITUS ULCER 25 0.0031
80 CHRONIC KIDNEY DISEASE 233 0.0031
81 MULTIPLE INJURIES 19 0.0030
82 PARAESTHESIA ORAL 43 0.0030
83 EMPHYSEMA 30 0.0030
84 EMBOLISM VENOUS 9 0.0030
85 SPINAL OSTEOARTHRITIS 26 0.0030
86 HYPOXIA 104 0.0030
87 ISCHAEMIC CARDIOMYOPATHY 9 0.0029
88 SLEEP APNOEA SYNDROME 56 0.0029
89 URINE FLOW DECREASED 7 0.0029
90 OXYGEN CONSUMPTION INCREASED 7 0.0029
91 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 18 0.0029
92 UPPER-AIRWAY COUGH SYNDROME 24 0.0029
93 LUNG INFILTRATION 25 0.0028
94 PELVIC FRACTURE 22 0.0028
95 FIBRIN D DIMER INCREASED 10 0.0028
96 CEREBRAL ATROPHY 11 0.0028
97 PULMONARY FUNCTION TEST DECREASED 12 0.0027
98 BLOOD CHLORIDE DECREASED 7 0.0027
99 CYSTIC FIBROSIS 15 0.0027
100 LIPOMA 7 0.0027
101 PULMONARY HYPERTENSION 56 0.0027
102 CREPITATIONS 8 0.0027
103 TEMPOROMANDIBULAR JOINT SYNDROME 7 0.0026
104 AORTIC VALVE INCOMPETENCE 11 0.0026
105 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 20 0.0026
106 ARTERIOSCLEROSIS CORONARY ARTERY 17 0.0026
107 MITRAL VALVE INCOMPETENCE 29 0.0026
108 UPPER RESPIRATORY TRACT INFECTION 118 0.0026
109 ATRIOVENTRICULAR BLOCK FIRST DEGREE 11 0.0025
110 DIVERTICULUM 18 0.0025
111 ATRIAL FLUTTER 20 0.0025
112 FAILURE TO THRIVE 13 0.0025
113 ENDOTRACHEAL INTUBATION 7 0.0025
114 SCLERODERMA 9 0.0025
115 ANHEDONIA 65 0.0025
116 RENAL FAILURE CHRONIC 19 0.0025
117 DIABETIC NEUROPATHY 12 0.0024
118 PRODUCT ADMINISTRATION INTERRUPTED 19 0.0024
119 AFFECT LABILITY 23 0.0024
120 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 13 0.0024
121 LUNG NEOPLASM 10 0.0023
122 URINE ANALYSIS ABNORMAL 7 0.0023
123 BLOOD CULTURE POSITIVE 7 0.0023
124 INCREASED UPPER AIRWAY SECRETION 12 0.0023
125 LEFT VENTRICULAR HYPERTROPHY 10 0.0023
126 BRONCHOPNEUMONIA 8 0.0023
127 METABOLIC ENCEPHALOPATHY 7 0.0023
128 REGURGITATION 8 0.0023
129 HOSPICE CARE 23 0.0023
130 LEFT VENTRICULAR FAILURE 8 0.0023
131 BRONCHITIS 172 0.0023
132 CENTRAL VENOUS CATHETERISATION 7 0.0023
133 THROMBOPHLEBITIS SUPERFICIAL 7 0.0023
134 PRODUCTIVE COUGH 110 0.0023
135 AORTIC STENOSIS 8 0.0023
136 PROSTATOMEGALY 9 0.0023
137 DUODENITIS 7 0.0023
138 PNEUMONIA ASPIRATION 57 0.0023
139 RESPIRATORY TRACT CONGESTION 36 0.0023
140 ANGIONEUROTIC OEDEMA 6 0.0022
141 INFUSION SITE PAIN 29 0.0022
142 RENAL TUBULAR NECROSIS 22 0.0022
143 NON-CARDIAC CHEST PAIN 7 0.0022
144 SINUS HEADACHE 13 0.0022
145 MULTIPLE ALLERGIES 17 0.0022
146 INTERVERTEBRAL DISC DEGENERATION 20 0.0022
147 CONGESTIVE CARDIOMYOPATHY 9 0.0022
148 INFUSION SITE ERYTHEMA 18 0.0021
149 FLUID OVERLOAD 31 0.0021
150 ARTERIOSCLEROSIS 20 0.0021
151 HYPOKALAEMIA 98 0.0021
152 FACE INJURY 8 0.0021
153 PULSE ABSENT 10 0.0021
154 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 8 0.0021
155 DIVERTICULUM INTESTINAL 9 0.0021
156 SEASONAL ALLERGY 29 0.0020
157 GASTROOESOPHAGEAL REFLUX DISEASE 164 0.0020
158 RESPIRATORY ACIDOSIS 8 0.0020
159 PRIAPISM 7 0.0020
160 PNEUMONIA FUNGAL 8 0.0020
161 DYSPNOEA EXERTIONAL 76 0.0020
162 RENAL CYST 16 0.0020
163 HYPOMAGNESAEMIA 28 0.0020
164 CANDIDIASIS 8 0.0020
165 INTERNATIONAL NORMALISED RATIO DECREASED 8 0.0020
166 PULMONARY CONGESTION 26 0.0020
167 BLOOD UREA INCREASED 33 0.0020
168 DYSLIPIDAEMIA 10 0.0020
169 PRODUCT USE COMPLAINT 31 0.0020
170 LIVER FUNCTION TEST INCREASED 42 0.0020
171 IRON DEFICIENCY ANAEMIA 18 0.0019
172 CONCOMITANT DISEASE AGGRAVATED 12 0.0019
173 OXYGEN SATURATION DECREASED 109 0.0019
174 RESPIRATORY FAILURE 141 0.0019
175 VENTRICULAR EXTRASYSTOLES 20 0.0019
176 SINUS CONGESTION 26 0.0019
177 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
178 TACHYPNOEA 26 0.0019
179 WHEEZING 113 0.0019
180 SPUTUM DISCOLOURED 18 0.0019
181 RESPIRATORY DISTRESS 52 0.0019
182 RESPIRATORY TRACT INFECTION 49 0.0019
183 CARDIAC FAILURE CONGESTIVE 151 0.0019
184 HAEMOGLOBIN ABNORMAL 12 0.0019
185 COVID-19 PNEUMONIA 22 0.0019
186 URINARY RETENTION 62 0.0019
187 SNORING 7 0.0018
188 OSTEOPENIA 28 0.0018
189 ENCEPHALOPATHY 45 0.0018
190 HEAD DISCOMFORT 32 0.0018
191 CLOSTRIDIUM DIFFICILE COLITIS 19 0.0018
192 CORONARY ARTERY DISEASE 54 0.0018
193 PHARYNGITIS 22 0.0018
194 SINUS BRADYCARDIA 17 0.0018
195 SECRETION DISCHARGE 22 0.0018
196 BLOOD SODIUM DECREASED 33 0.0017
197 CARDIAC VALVE DISEASE 10 0.0017
198 INCORRECT DRUG ADMINISTRATION DURATION 49 0.0017
199 RENAL FAILURE 231 0.0017
200 SINUSITIS 177 0.0017
201 PNEUMONIA 557 0.0017
202 CAROTID ARTERY STENOSIS 6 0.0017
203 TRIGGER FINGER 7 0.0017
204 AORTIC ANEURYSM 13 0.0017
205 TIBIA FRACTURE 8 0.0017
206 OBESITY 27 0.0017
207 PROCEDURAL PAIN 47 0.0017
208 SPINAL COLUMN STENOSIS 8 0.0017
209 HERPES SIMPLEX 11 0.0017
210 BEDRIDDEN 22 0.0017
211 FREQUENT BOWEL MOVEMENTS 45 0.0017
212 TYPE 1 DIABETES MELLITUS 10 0.0017
213 LEUKOCYTOSIS 30 0.0017
214 HYPERCHOLESTEROLAEMIA 16 0.0017
215 BUNDLE BRANCH BLOCK LEFT 7 0.0016
216 INTERNATIONAL NORMALISED RATIO INCREASED 47 0.0016
217 CYTOKINE RELEASE SYNDROME 33 0.0016
218 ABSCESS LIMB 7 0.0016
219 POST-TRAUMATIC STRESS DISORDER 11 0.0016
220 VITAMIN D DEFICIENCY 16 0.0016
221 CHOKING 32 0.0016
222 NASAL DISCOMFORT 13 0.0016
223 INTERVERTEBRAL DISC DISORDER 7 0.0016
224 COLITIS 62 0.0016
225 ELECTROLYTE IMBALANCE 19 0.0016
226 HYPERKERATOSIS 9 0.0016
227 MUSCULOSKELETAL CHEST PAIN 25 0.0016
228 INFUSION SITE EXTRAVASATION 10 0.0016
229 ECCHYMOSIS 11 0.0016
230 PLEURAL EFFUSION 97 0.0016
231 HAEMORRHAGIC ANAEMIA 7 0.0016
232 APATHY 23 0.0016
233 DRY THROAT 16 0.0016
234 SPINAL COMPRESSION FRACTURE 13 0.0016
235 COMMUNICATION DISORDER 6 0.0016
236 RECTAL HAEMORRHAGE 67 0.0016
237 CARDIOMYOPATHY 23 0.0016
238 ACUTE KIDNEY INJURY 238 0.0016
239 SINUS TACHYCARDIA 22 0.0015
240 MENTAL STATUS CHANGES 43 0.0015
241 LUNG INFECTION 24 0.0015
242 HAEMOPTYSIS 43 0.0015
243 ATRIAL FIBRILLATION 150 0.0015
244 HYPOVOLAEMIA 9 0.0015
245 ACUTE RESPIRATORY DISTRESS SYNDROME 27 0.0015
246 DECREASED INTEREST 9 0.0015
247 SOMNAMBULISM 10 0.0015
248 RENAL INJURY 45 0.0015
249 INCONTINENCE 16 0.0015
250 HAEMATOCRIT DECREASED 30 0.0015
251 ARTHRITIS INFECTIVE 7 0.0015
252 MAJOR DEPRESSION 11 0.0015
253 PROTHROMBIN TIME PROLONGED 9 0.0015
254 POOR QUALITY SLEEP 32 0.0015
255 UNRESPONSIVE TO STIMULI 38 0.0015
256 HYDRONEPHROSIS 11 0.0015
257 PNEUMONITIS 40 0.0015
258 GASTRITIS 38 0.0014
259 LIMB INJURY 39 0.0014
260 BACTERAEMIA 17 0.0014
261 CELLULITIS 72 0.0014
262 CHOLECYSTITIS 17 0.0014
263 RIGHT VENTRICULAR FAILURE 10 0.0014
264 HYPONATRAEMIA 80 0.0014
265 STAPHYLOCOCCAL SEPSIS 7 0.0014
266 PULMONARY MASS 21 0.0014
267 PULMONARY OEDEMA 63 0.0014
268 ELECTROCARDIOGRAM ABNORMAL 11 0.0014
269 BRONCHOSPASM 20 0.0014
270 HYPERAMMONAEMIA 7 0.0014
271 BACTERIAL INFECTION 26 0.0014
272 VENTRICULAR TACHYCARDIA 23 0.0014
273 NEPHROPATHY 13 0.0014
274 CORONARY ARTERY STENOSIS 7 0.0014
275 OSTEOARTHRITIS 59 0.0014
276 EXERCISE TOLERANCE DECREASED 8 0.0014
277 MUSCLE SPASTICITY 17 0.0014
278 COUGH 388 0.0014
279 BACK INJURY 15 0.0014
280 OESOPHAGITIS 15 0.0014
281 ASPIRATION 15 0.0014
282 ANKLE FRACTURE 21 0.0014
283 BRADYKINESIA 8 0.0014
284 EAR INFECTION 36 0.0014
285 GLUCOSE TOLERANCE IMPAIRED 8 0.0014
286 IMMUNE EFFECTOR CELL-ASSOCIATED NEUROTOXICITY SYNDROME 8 0.0013
287 CYSTITIS 43 0.0013
288 QUALITY OF LIFE DECREASED 18 0.0013
289 ODYNOPHAGIA 8 0.0013
290 TRANSFUSION 14 0.0013
291 HAEMORRHOIDS 26 0.0013
292 INFUSION RELATED REACTION 88 0.0013
293 NASAL CONGESTION 78 0.0013
294 INTERVERTEBRAL DISC PROTRUSION 29 0.0013
295 FRACTURE 25 0.0013
296 EOSINOPHIL COUNT INCREASED 11 0.0013
297 DERMATITIS CONTACT 15 0.0013
298 MICTURITION URGENCY 15 0.0013
299 BODY HEIGHT DECREASED 14 0.0013
300 LIVER FUNCTION TEST ABNORMAL 38 0.0013
301 RESPIRATION ABNORMAL 9 0.0013
302 JOINT EFFUSION 9 0.0013
303 INCREASED TENDENCY TO BRUISE 12 0.0013
304 DROOLING 9 0.0013
305 GINGIVITIS 7 0.0013
306 ATRIOVENTRICULAR BLOCK 10 0.0013
307 BLOOD POTASSIUM INCREASED 21 0.0013
308 HEPATIC STEATOSIS 24 0.0013
309 ASPARTATE AMINOTRANSFERASE INCREASED 68 0.0013
310 GASTROENTERITIS VIRAL 23 0.0013
311 SEPSIS 142 0.0013
312 INFUSION SITE SWELLING 8 0.0013
313 PYELONEPHRITIS 11 0.0013
314 CHOKING SENSATION 7 0.0013
315 INITIAL INSOMNIA 13 0.0013
316 RIB FRACTURE 26 0.0013
317 CARDIAC TAMPONADE 6 0.0013
318 SINUS DISORDER 25 0.0013
319 OEDEMA PERIPHERAL 152 0.0012
320 BRADYCARDIA 66 0.0012
321 GASTROENTERITIS 18 0.0012
322 RENAL FAILURE ACUTE 52 0.0012
323 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21 0.0012
324 HYPOPHOSPHATAEMIA 9 0.0012
325 ASTHMA 137 0.0012
326 PERICARDIAL EFFUSION 28 0.0012
327 CARDIAC FAILURE ACUTE 8 0.0012
328 URINARY TRACT INFECTION 204 0.0012
329 SKIN LACERATION 13 0.0012
330 CHOLECYSTITIS CHRONIC 8 0.0012
331 INJURY 84 0.0012
332 HEART RATE IRREGULAR 27 0.0012
333 ATRIAL SEPTAL DEFECT 10 0.0012
334 DEHYDRATION 159 0.0012
335 COLITIS ISCHAEMIC 8 0.0012
336 TROPONIN INCREASED 9 0.0012
337 DYSPEPSIA 116 0.0012
338 INSURANCE ISSUE 18 0.0012
339 GOUT 21 0.0012
340 NERVE INJURY 13 0.0012
341 EAR DISCOMFORT 12 0.0012
342 TENDONITIS 18 0.0012
343 MALNUTRITION 13 0.0012
344 OEDEMA 63 0.0012
345 APNOEA 9 0.0012
346 TENDERNESS 12 0.0012
347 PULMONARY HAEMORRHAGE 9 0.0011
348 RESPIRATORY SYNCYTIAL VIRUS INFECTION 10 0.0011
349 EXPIRED PRODUCT ADMINISTERED 38 0.0011
350 CARPAL TUNNEL SYNDROME 16 0.0011
351 RESPIRATORY DEPRESSION 14 0.0011
352 ALANINE AMINOTRANSFERASE INCREASED 70 0.0011
353 IMMUNE SYSTEM DISORDER 15 0.0011
354 CONJUNCTIVITIS 21 0.0011
355 GINGIVAL PAIN 9 0.0011
356 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 54 0.0011
357 BLOOD DISORDER 9 0.0011
358 TUBULOINTERSTITIAL NEPHRITIS 21 0.0011
359 RESTLESSNESS 41 0.0011
360 THIRST 20 0.0011
361 LIGAMENT SPRAIN 11 0.0011
362 PHOTOPSIA 7 0.0011
363 OROPHARYNGEAL DISCOMFORT 10 0.0011
364 PULMONARY ARTERIAL HYPERTENSION 16 0.0011
365 GASTROINTESTINAL HAEMORRHAGE 92 0.0011
366 CARDIO-RESPIRATORY ARREST 46 0.0011
367 CHOLELITHIASIS 36 0.0011
368 BLOOD POTASSIUM DECREASED 33 0.0011
369 HERPES ZOSTER 63 0.0011
370 DYSPHAGIA 104 0.0011
371 ATAXIA 13 0.0011
372 HYPOPHAGIA 28 0.0011
373 PULMONARY FIBROSIS 21 0.0011
374 DEEP VEIN THROMBOSIS 71 0.0011
375 ORTHOSTATIC HYPOTENSION 19 0.0011
376 BLOOD ALKALINE PHOSPHATASE INCREASED 27 0.0011
377 HYPERTENSION 230 0.0011
378 ACUTE MYOCARDIAL INFARCTION 32 0.0011
379 HIATUS HERNIA 14 0.0011
380 VENTRICULAR FIBRILLATION 12 0.0011
381 EAR PAIN 21 0.0011
382 ANGINA UNSTABLE 7 0.0011
383 PNEUMOTHORAX 17 0.0011
384 REFUSAL OF TREATMENT BY PATIENT 7 0.0011
385 COGNITIVE DISORDER 50 0.0011
386 UPPER GASTROINTESTINAL HAEMORRHAGE 18 0.0011
387 THERAPEUTIC RESPONSE UNEXPECTED 48 0.0011
388 OSTEOPOROSIS 44 0.0011
389 TYPE 2 DIABETES MELLITUS 36 0.0011
390 HAEMATOCHEZIA 59 0.0011
391 HYPOTHYROIDISM 34 0.0011
392 GALLBLADDER DISORDER 19 0.0011
393 HYPOAESTHESIA ORAL 16 0.0011
394 ANXIETY 302 0.0011
395 IMPAIRED DRIVING ABILITY 12 0.0011
396 MYOCARDIAL ISCHAEMIA 12 0.0011
397 WEIGHT FLUCTUATION 11 0.0011
398 HAEMODYNAMIC INSTABILITY 8 0.0010
399 DERMATITIS 22 0.0010
400 RED BLOOD CELL COUNT DECREASED 30 0.0010
401 POSTERIOR REVERSIBLE ENCEPHALOPATHY SYNDROME 10 0.0010
402 LEFT VENTRICULAR DYSFUNCTION 7 0.0010
403 JOINT RANGE OF MOTION DECREASED 14 0.0010
404 LETHARGY 60 0.0010
405 JOINT DISLOCATION 11 0.0010
406 MUSCLE STRAIN 9 0.0010
407 BLOOD URIC ACID INCREASED 6 0.0010
408 NECK PAIN 58 0.0010
409 RHINORRHOEA 67 0.0010
410 FOOD ALLERGY 8 0.0010
411 DYSPNOEA 586 0.0010
412 HERNIA 20 0.0010
413 ANAEMIA 196 0.0010
414 IMPAIRED GASTRIC EMPTYING 14 0.0010
415 TUMOUR LYSIS SYNDROME 9 0.0010
416 BRAIN FOG 16 0.0010
417 DECREASED ACTIVITY 11 0.0010
418 SEPTIC SHOCK 44 0.0010
419 LARGE INTESTINE POLYP 7 0.0010
420 ACTIVITIES OF DAILY LIVING IMPAIRED 20 0.0010
421 BLOOD ALBUMIN DECREASED 8 0.0010
422 CLOSTRIDIUM DIFFICILE INFECTION 22 0.0010
423 CARDIAC PACEMAKER INSERTION 6 0.0010
424 IMMUNODEFICIENCY 15 0.0010
425 HYPOTENSION 201 0.0010
426 OBSESSIVE-COMPULSIVE DISORDER 8 0.0010
427 DENTAL CARIES 11 0.0010
428 DISEASE RECURRENCE 47 0.0010
429 HAND FRACTURE 7 0.0010
430 GLAUCOMA 19 0.0010
431 SARS-COV-2 TEST POSITIVE 13 0.0010
432 BLOOD CREATININE INCREASED 64 0.0010
433 DELIRIUM 34 0.0010
434 URINARY INCONTINENCE 29 0.0010
435 CONTUSION 94 0.0010
436 ABNORMAL FAECES 8 0.0010
437 SMALL INTESTINAL OBSTRUCTION 12 0.0010
438 IMPAIRED QUALITY OF LIFE 14 0.0010
439 EMOTIONAL DISORDER 30 0.0010
440 ESCHERICHIA INFECTION 8 0.0010
441 HYPERKALAEMIA 34 0.0010
442 GENERALISED OEDEMA 12 0.0010
443 TACHYCARDIA 86 0.0010
444 COVID-19 169 0.0010
445 INTERNAL HAEMORRHAGE 11 0.0010
446 FAECES SOFT 7 0.0010
447 NIGHT SWEATS 31 0.0010
448 VIRAL INFECTION 32 0.0010
449 OROPHARYNGEAL PAIN 89 0.0010
450 THROAT TIGHTNESS 26 0.0010
451 DIABETES MELLITUS INADEQUATE CONTROL 17 0.0010
452 SLEEP DISORDER 67 0.0009
453 BLINDNESS TRANSIENT 7 0.0009
454 CANDIDA INFECTION 16 0.0009
455 FIBROMYALGIA 23 0.0009
456 FULL BLOOD COUNT DECREASED 19 0.0009
457 STAPHYLOCOCCAL INFECTION 31 0.0009
458 COLITIS ULCERATIVE 42 0.0009
459 SPLENOMEGALY 11 0.0009
460 LUNG DISORDER 46 0.0009
461 RETCHING 20 0.0009
462 POST PROCEDURAL COMPLICATION 18 0.0009
463 LOWER LIMB FRACTURE 18 0.0009
464 RESPIRATORY DISORDER 28 0.0009
465 WEIGHT DECREASED 261 0.0009
466 INFLUENZA 104 0.0009
467 FUNGAL INFECTION 31 0.0009
468 SWOLLEN TONGUE 29 0.0009
469 CONTRAINDICATED PRODUCT ADMINISTERED 28 0.0009
470 INCORRECT PRODUCT ADMINISTRATION DURATION 20 0.0009
471 BIPOLAR DISORDER 10 0.0009
472 ANGINA PECTORIS 26 0.0009
473 NOCTURIA 11 0.0009
474 HAEMATURIA 31 0.0009
475 FEBRILE NEUTROPENIA 60 0.0009
476 CONGENITAL ANOMALY 7 0.0009
477 APHTHOUS ULCER 7 0.0009
478 COAGULOPATHY 15 0.0009
479 BASAL CELL CARCINOMA 14 0.0009
480 SPEECH DISORDER 47 0.0009
481 ATRIOVENTRICULAR BLOCK COMPLETE 6 0.0009
482 GASTRIC ULCER 17 0.0009
483 CONSTIPATION 195 0.0009
484 ORAL PAIN 20 0.0009
485 DIABETES MELLITUS 68 0.0009
486 SKIN INFECTION 10 0.0009
487 BLOOD CALCIUM DECREASED 10 0.0009
488 WHITE BLOOD CELL COUNT INCREASED 34 0.0009
489 IRRITABLE BOWEL SYNDROME 19 0.0009
490 EXTRAPYRAMIDAL DISORDER 22 0.0009
491 THROMBOCYTOPENIA 99 0.0009
492 FLUID RETENTION 45 0.0009
493 DEPRESSION 201 0.0009
494 RESTLESS LEGS SYNDROME 16 0.0009
495 MOOD SWINGS 28 0.0009
496 BONE DISORDER 16 0.0009
497 SCAB 10 0.0009
498 FAECES DISCOLOURED 19 0.0009
499 DRY MOUTH 71 0.0009
500 TEMPERATURE INTOLERANCE 9 0.0009
501 HYPERSOMNIA 25 0.0009
502 BRAIN OEDEMA 11 0.0009
503 RESPIRATORY ARREST 24 0.0009
504 PYREXIA 301 0.0009
505 VERTIGO 53 0.0009
506 RHINITIS 7 0.0009
507 MULTI-ORGAN FAILURE 15 0.0009
508 UROSEPSIS 8 0.0009
509 EYE DISCHARGE 9 0.0009
510 PRESYNCOPE 21 0.0009
511 NEURALGIA 21 0.0009
512 POLLAKIURIA 36 0.0009
513 PULMONARY EMBOLISM 82 0.0009
514 HEPATIC FAILURE 26 0.0009
515 SUBSTANCE ABUSE 7 0.0009
516 BLOOD CHOLESTEROL INCREASED 40 0.0009
517 HAEMOGLOBIN DECREASED 88 0.0009
518 FLANK PAIN 8 0.0009
519 CHEST PAIN 158 0.0009
520 HICCUPS 7 0.0009
521 PHARYNGEAL OEDEMA 13 0.0008
522 FOOT FRACTURE 16 0.0008
523 EMBOLISM 7 0.0008
524 DYSURIA 31 0.0008
525 EJECTION FRACTION DECREASED 13 0.0008
526 CARDIOGENIC SHOCK 12 0.0008
527 WRIST FRACTURE 10 0.0008
528 HAEMODIALYSIS 7 0.0008
529 BODY TEMPERATURE INCREASED 17 0.0008
530 CHEST DISCOMFORT 85 0.0008
531 FALL 276 0.0008
532 TOOTHACHE 15 0.0008
533 LACRIMATION INCREASED 25 0.0008
534 BLOOD PRESSURE INCREASED 126 0.0008
535 WOUND INFECTION 9 0.0008
536 SOMNOLENCE 165 0.0008
537 CONFUSIONAL STATE 132 0.0008
538 TOOTH FRACTURE 9 0.0008
539 ARTHROPOD BITE 6 0.0008
540 SYNCOPE 81 0.0008
541 EMOTIONAL DISTRESS 98 0.0008
542 HYSTERECTOMY 7 0.0008
543 ILEUS 10 0.0008
544 DYSPHONIA 47 0.0008
545 DEAFNESS 21 0.0008
546 TRANSIENT ISCHAEMIC ATTACK 27 0.0008
547 BONE DENSITY DECREASED 25 0.0008
548 DYSARTHRIA 30 0.0008
549 HYPOCALCAEMIA 15 0.0008
550 BLOOD URINE PRESENT 15 0.0008
551 ROAD TRAFFIC ACCIDENT 33 0.0008
552 EYELID PTOSIS 8 0.0008
553 ACIDOSIS 6 0.0008
554 NEOPLASM 9 0.0008
555 TARDIVE DYSKINESIA 22 0.0008
556 ROTATOR CUFF SYNDROME 10 0.0008
557 COMA 37 0.0008
558 DEVELOPMENTAL DELAY 7 0.0008
559 EPISTAXIS 58 0.0008
560 OSTEOMYELITIS 14 0.0008
561 RENAL DISORDER 36 0.0008
562 BACK PAIN 179 0.0008
563 ACUTE MYELOID LEUKAEMIA 12 0.0008
564 SUBDURAL HAEMATOMA 11 0.0008
565 NEUROPATHY PERIPHERAL 73 0.0008
566 PETECHIAE 8 0.0008
567 TOOTH DISORDER 17 0.0008
568 AFFECTIVE DISORDER 6 0.0008
569 HYPOGLYCAEMIA 37 0.0008
570 DYSKINESIA 31 0.0008
571 LYMPHADENOPATHY 27 0.0008
572 HYPERTHYROIDISM 11 0.0008
573 SCAR 13 0.0008
574 TOOTH INFECTION 10 0.0008
575 BLOOD IRON DECREASED 9 0.0008
576 NERVE COMPRESSION 7 0.0008
577 DIVERTICULITIS 21 0.0008
578 DYSGEUSIA 56 0.0008
579 SCIATICA 12 0.0008
580 DEMENTIA 21 0.0008
581 EATING DISORDER 16 0.0008
582 CARDIAC ARREST 62 0.0008
583 JOINT INJURY 16 0.0007
584 ABDOMINAL PAIN 174 0.0007
585 LOCAL SWELLING 13 0.0007
586 LACERATION 7 0.0007
587 HYPOACUSIS 32 0.0007
588 HYPERGLYCAEMIA 27 0.0007
589 SHOCK 17 0.0007
590 SPINAL DISORDER 7 0.0007
591 BACK DISORDER 12 0.0007
592 COLD SWEAT 13 0.0007
593 THROAT IRRITATION 33 0.0007
594 LYMPHOCYTE COUNT DECREASED 13 0.0007
595 PALLOR 20 0.0007
596 ABDOMINAL DISTENSION 76 0.0007
597 HEART RATE INCREASED 72 0.0007
598 PHOTOSENSITIVITY REACTION 12 0.0007
599 BLOOD COUNT ABNORMAL 11 0.0007
600 PSYCHOMOTOR HYPERACTIVITY 12 0.0007
601 DIZZINESS POSTURAL 7 0.0007
602 STEVENS-JOHNSON SYNDROME 16 0.0007
603 DYSSTASIA 21 0.0007
604 OBSTRUCTIVE AIRWAYS DISORDER 8 0.0007
605 ASTHENIA 270 0.0007
606 PAIN 441 0.0007
607 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 51 0.0007
608 APHONIA 10 0.0007
609 PANCYTOPENIA 40 0.0007
610 THYROID DISORDER 11 0.0007
611 SNEEZING 16 0.0007
612 HEART RATE DECREASED 25 0.0007
613 LABORATORY TEST ABNORMAL 21 0.0007
614 DISSEMINATED INTRAVASCULAR COAGULATION 10 0.0007
615 CHROMATURIA 16 0.0007
616 EYE INFECTION 8 0.0007
617 DELUSION 11 0.0007
618 DEPRESSED LEVEL OF CONSCIOUSNESS 28 0.0007
619 PAIN IN JAW 20 0.0007
620 FLATULENCE 40 0.0007
621 INSOMNIA 187 0.0007
622 CHOLECYSTECTOMY 8 0.0007
623 SALIVARY HYPERSECRETION 7 0.0007
624 DRUG INTERACTION 111 0.0007
625 CHILLS 82 0.0007
626 CYANOSIS 11 0.0007
627 INFECTION 101 0.0007
628 ANURIA 6 0.0007
629 BLOOD MAGNESIUM DECREASED 6 0.0007
630 HEAD INJURY 22 0.0007
631 TREATMENT NONCOMPLIANCE 38 0.0007
632 PRURITUS GENERALISED 15 0.0007
633 ULCER 11 0.0007
634 NODULE 9 0.0007
635 HEPATIC ENZYME INCREASED 47 0.0007
636 COMPLICATION ASSOCIATED WITH DEVICE 10 0.0007
637 TOOTH ABSCESS 7 0.0007
638 SEDATION 18 0.0007
639 VASCULITIS 8 0.0007
640 ARTHRITIS 54 0.0007
641 SLUGGISHNESS 7 0.0007
642 BLOOD CALCIUM INCREASED 6 0.0007
643 NEUTROPHIL COUNT INCREASED 7 0.0007
644 SPINAL PAIN 8 0.0007
645 FEELING JITTERY 13 0.0007
646 IRRITABILITY 41 0.0007
647 PERIPHERAL SWELLING 105 0.0007
648 DRY EYE 34 0.0007
649 ASCITES 20 0.0007
650 BLOOD TRIGLYCERIDES INCREASED 12 0.0007
651 NEPHROLITHIASIS 31 0.0007
652 HYPERBILIRUBINAEMIA 7 0.0007
653 TOOTH LOSS 14 0.0007
654 ILL-DEFINED DISORDER 41 0.0007
655 DRUG EFFECT LESS THAN EXPECTED 10 0.0007
656 TRANSAMINASES INCREASED 15 0.0007
657 DISCOMFORT 41 0.0007
658 CATARACT 40 0.0007
659 MIGRAINE 64 0.0007
660 DYSTONIA 13 0.0007
661 TREMOR 111 0.0007
662 DECREASED APPETITE 155 0.0007
663 ELECTROCARDIOGRAM QT PROLONGED 24 0.0007
664 ANAL INCONTINENCE 6 0.0007
665 SKIN FISSURES 13 0.0007
666 SCRATCH 7 0.0007
667 GAIT DISTURBANCE 127 0.0007
668 PELVIC PAIN 12 0.0007
669 BALANCE DISORDER 57 0.0007
670 BURSITIS 8 0.0007
671 INFLAMMATION 34 0.0007
672 DISABILITY 13 0.0007
673 SKIN LESION 18 0.0007
674 NO THERAPEUTIC RESPONSE 8 0.0007
675 INTENTIONAL OVERDOSE 42 0.0007
676 BLOOD PRESSURE ABNORMAL 13 0.0007
677 HIP FRACTURE 21 0.0007
678 VOMITING 307 0.0007
679 SKIN DISCOLOURATION 30 0.0007
680 DIARRHOEA 421 0.0007
681 GLOMERULAR FILTRATION RATE DECREASED 8 0.0007
682 ILLNESS 67 0.0006
683 HALLUCINATION 49 0.0006
684 DEVICE RELATED INFECTION 10 0.0006
685 SPINAL OPERATION 8 0.0006
686 HEMIPARESIS 11 0.0006
687 VISION BLURRED 89 0.0006
688 MEDICATION ERROR 36 0.0006
689 UNEVALUABLE EVENT 49 0.0006
690 ORAL DISCOMFORT 9 0.0006
691 THINKING ABNORMAL 12 0.0006
692 WOUND 18 0.0006
693 MASS 9 0.0006
694 MIDDLE INSOMNIA 12 0.0006
695 DEFORMITY 6 0.0006
696 DIZZINESS 320 0.0006
697 TASTE DISORDER 13 0.0006
698 INTENTIONAL PRODUCT MISUSE 56 0.0006
699 DEVICE OCCLUSION 9 0.0006
700 MUSCULOSKELETAL DISCOMFORT 11 0.0006
701 JOINT SWELLING 77 0.0006
702 LOWER RESPIRATORY TRACT INFECTION 29 0.0006
703 COMPLETED SUICIDE 53 0.0006
704 MULTIPLE ORGAN DYSFUNCTION SYNDROME 18 0.0006
705 PALPITATIONS 74 0.0006
706 NAUSEA 500 0.0006
707 MUSCULOSKELETAL DISORDER 12 0.0006
708 METABOLIC ACIDOSIS 20 0.0006
709 PAIN IN EXTREMITY 184 0.0006
710 MUSCLE SPASMS 114 0.0006
711 PLATELET COUNT DECREASED 66 0.0006
712 FATIGUE 482 0.0006
713 SKIN ULCER 16 0.0006
714 HAEMATOMA 16 0.0006
715 PLASMA CELL MYELOMA 24 0.0006
716 SURGERY 36 0.0006
717 KIDNEY INFECTION 12 0.0006
718 FEELING COLD 17 0.0006
719 JOINT STIFFNESS 16 0.0006
720 BODY TEMPERATURE DECREASED 6 0.0006
721 HEADACHE 380 0.0006
722 HYPERHIDROSIS 78 0.0006
723 PANCREATITIS 32 0.0006
724 SPINAL FRACTURE 12 0.0006
725 BONE LOSS 9 0.0006
726 MOBILITY DECREASED 43 0.0006
727 INTENTIONAL DOSE OMISSION 17 0.0006
728 SUICIDE ATTEMPT 36 0.0006
729 TOXICITY TO VARIOUS AGENTS 100 0.0006
730 FEEDING DISORDER 12 0.0006
731 CEREBROVASCULAR ACCIDENT 100 0.0006
732 CARDIAC DISORDER 55 0.0006
733 DRUG TOXICITY 8 0.0006
734 HEPATITIS 15 0.0006
735 CARDIAC FAILURE 47 0.0006
736 MYOCARDIAL INFARCTION 102 0.0006
737 MALAISE 256 0.0006
738 PERIPHERAL COLDNESS 8 0.0006
739 NASOPHARYNGITIS 107 0.0006
740 DISORIENTATION 23 0.0006
741 ANAPHYLACTIC REACTION 32 0.0006
742 ERYTHEMA 119 0.0006
743 LOSS OF CONSCIOUSNESS 74 0.0006
744 ARTHROPATHY 32 0.0006
745 MUSCULOSKELETAL PAIN 30 0.0006
746 LIP SWELLING 19 0.0006
747 GAIT INABILITY 19 0.0006
748 PRESCRIBED OVERDOSE 11 0.0006
749 HOSPITALISATION 87 0.0006
750 NEUTROPHIL COUNT DECREASED 23 0.0006
751 DRUG ERUPTION 10 0.0006
752 BLOOD PRESSURE SYSTOLIC INCREASED 11 0.0006
753 DIALYSIS 8 0.0006
754 BONE PAIN 33 0.0006
755 GENERAL PHYSICAL HEALTH DETERIORATION 65 0.0006
756 NERVOUSNESS 29 0.0006
757 HAEMATEMESIS 14 0.0006
758 MENTAL DISORDER 24 0.0006
759 PRESCRIBED UNDERDOSE 11 0.0006
760 HYPOKINESIA 8 0.0006
761 THROMBOSIS 44 0.0005
762 SWELLING 51 0.0005
763 AGITATION 40 0.0005
764 DRUG LEVEL INCREASED 9 0.0005
765 CONDITION AGGRAVATED 165 0.0005
766 BLOOD PRESSURE DECREASED 36 0.0005
767 RASH GENERALISED 14 0.0005
768 DISTURBANCE IN ATTENTION 29 0.0005
769 PLATELET COUNT INCREASED 7 0.0005
770 ABDOMINAL DISCOMFORT 90 0.0005
771 SUICIDAL IDEATION 49 0.0005
772 FEELING ABNORMAL 128 0.0005
773 HEPATIC CIRRHOSIS 10 0.0005
774 INTESTINAL OBSTRUCTION 20 0.0005
775 ABNORMAL BEHAVIOUR 21 0.0005
776 APHASIA 16 0.0005
777 LIVER INJURY 13 0.0005
778 DRUG INTOLERANCE 51 0.0005
779 MUSCULAR WEAKNESS 60 0.0005
780 ARRHYTHMIA 25 0.0005
781 PRODUCT AVAILABILITY ISSUE 12 0.0005
782 OSTEONECROSIS OF JAW 13 0.0005
783 CONVULSION 30 0.0005
784 AMNESIA 34 0.0005
785 PARANOIA 9 0.0005
786 PANIC ATTACK 19 0.0005
787 UNDERDOSE 38 0.0005
788 BLOOD BILIRUBIN INCREASED 14 0.0005
789 LIMB DISCOMFORT 16 0.0005
790 GINGIVAL BLEEDING 7 0.0005
791 ORAL HERPES 10 0.0005
792 CORONARY ARTERY OCCLUSION 7 0.0005
793 ABDOMINAL PAIN UPPER 105 0.0005
794 ALTERED STATE OF CONSCIOUSNESS 11 0.0005
795 SWELLING FACE 33 0.0005
796 BLOOD LACTATE DEHYDROGENASE INCREASED 8 0.0005
797 COORDINATION ABNORMAL 7 0.0005
798 PHARMACEUTICAL PRODUCT COMPLAINT 13 0.0005
799 DIPLOPIA 13 0.0005
800 WEIGHT INCREASED 112 0.0005
801 BLOOD PRESSURE FLUCTUATION 12 0.0005
802 MELAENA 11 0.0005
803 BLOOD GLUCOSE DECREASED 24 0.0005
804 BLISTER 28 0.0005
805 RASH PRURITIC 27 0.0005
806 PRODUCT ADMINISTRATION ERROR 10 0.0005
807 ADRENAL INSUFFICIENCY 6 0.0005
808 PRODUCT DOSE OMISSION IN ERROR 14 0.0005
809 NIGHTMARE 17 0.0005
810 MUSCULOSKELETAL STIFFNESS 43 0.0005
811 CYTOPENIA 6 0.0005
812 URTICARIA 82 0.0005
813 THERAPY NON-RESPONDER 22 0.0005
814 RENAL IMPAIRMENT 41 0.0005
815 HAEMORRHAGE 51 0.0005
816 MEMORY IMPAIRMENT 67 0.0005
817 MULTIPLE FRACTURES 8 0.0005
818 HYPERSENSITIVITY 90 0.0005
819 SEIZURE 56 0.0005
820 FEAR 13 0.0005
821 WHITE BLOOD CELL COUNT DECREASED 52 0.0005
822 PHOTOPHOBIA 9 0.0005
823 ABDOMINAL PAIN LOWER 12 0.0005
824 HALLUCINATION, VISUAL 10 0.0005
825 LIVER DISORDER 21 0.0005
826 MYALGIA 80 0.0005
827 ARTHRALGIA 195 0.0005
828 VISUAL IMPAIRMENT 58 0.0005
829 RASH 204 0.0005
830 ERUCTATION 9 0.0005
831 ACCIDENTAL OVERDOSE 17 0.0005
832 HOT FLUSH 35 0.0005
833 STOMATITIS 28 0.0005
834 EYE PAIN 26 0.0005
835 DEVICE FAILURE 7 0.0005
836 RASH MACULAR 16 0.0005
837 TINNITUS 21 0.0005
838 NEUROTOXICITY 8 0.0005
839 DRUG ABUSE 38 0.0005
840 METASTASES TO LIVER 8 0.0005
841 MENTAL IMPAIRMENT 11 0.0005
842 BLOOD CREATINE PHOSPHOKINASE INCREASED 13 0.0005
843 PRODUCT DOSE OMISSION ISSUE 132 0.0004
844 THERAPY CESSATION 23 0.0004
845 THERAPY INTERRUPTED 32 0.0004
846 RASH PAPULAR 10 0.0004
847 FEELING HOT 27 0.0004
848 MOOD ALTERED 12 0.0004
849 PRURITUS 169 0.0004
850 AKATHISIA 6 0.0004
851 DISEASE PROGRESSION 52 0.0004
852 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 24 0.0004
853 OFF LABEL USE 381 0.0004
854 ABNORMAL DREAMS 12 0.0004
855 MUSCLE TWITCHING 10 0.0004
856 INTERSTITIAL LUNG DISEASE 21 0.0004
857 MUSCLE TIGHTNESS 7 0.0004
858 ANGIOEDEMA 19 0.0004
859 KNEE ARTHROPLASTY 9 0.0004
860 MOUTH ULCERATION 9 0.0004
861 METASTASES TO BONE 7 0.0004
862 IMPAIRED HEALING 14 0.0004
863 PARAESTHESIA 67 0.0004
864 EYE DISORDER 14 0.0004
865 GASTROINTESTINAL DISORDER 38 0.0004
866 IMPAIRED WORK ABILITY 9 0.0004
867 MALIGNANT NEOPLASM PROGRESSION 43 0.0004
868 SKIN DISORDER 14 0.0004
869 CEREBRAL HAEMORRHAGE 15 0.0004
870 RASH ERYTHEMATOUS 20 0.0004
871 EYE PRURITUS 14 0.0004
872 HYPOAESTHESIA 62 0.0004
873 LOCALISED INFECTION 10 0.0004
874 CEREBRAL INFARCTION 10 0.0004
875 GASTRIC DISORDER 14 0.0004
876 ABASIA 10 0.0004
877 HEPATOTOXICITY 9 0.0004
878 UPPER LIMB FRACTURE 8 0.0004
879 EYE IRRITATION 23 0.0004
880 PSORIASIS 52 0.0004
881 GLYCOSYLATED HAEMOGLOBIN INCREASED 10 0.0004
882 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 71 0.0004
883 VISUAL ACUITY REDUCED 13 0.0004
884 INCORRECT DOSE ADMINISTERED 89 0.0004
885 ERECTILE DYSFUNCTION 10 0.0004
886 INTENTIONAL PRODUCT USE ISSUE 34 0.0004
887 INTENTIONAL DRUG MISUSE 8 0.0004
888 BLOOD GLUCOSE INCREASED 72 0.0004
889 OVERDOSE 81 0.0004
890 DIABETIC KETOACIDOSIS 9 0.0004
891 PRODUCT USE ISSUE 70 0.0004
892 DEATH 314 0.0004
893 SEROTONIN SYNDROME 7 0.0004
894 DRUG PRESCRIBING ERROR 7 0.0004
895 CYTOMEGALOVIRUS INFECTION 6 0.0004
896 AGEUSIA 9 0.0004
897 NEUTROPENIA 49 0.0004
898 LEUKOPENIA 18 0.0004
899 DEPRESSED MOOD 19 0.0004
900 CRYING 13 0.0004
901 GLOSSODYNIA 8 0.0004
902 PRODUCT USE IN UNAPPROVED INDICATION 88 0.0004
903 ANGER 12 0.0004
904 CARDIOVASCULAR DISORDER 9 0.0004
905 NERVOUS SYSTEM DISORDER 11 0.0004
906 RHEUMATOID ARTHRITIS 40 0.0004
907 MOVEMENT DISORDER 11 0.0003
908 PSYCHOTIC DISORDER 10 0.0003
909 TREATMENT FAILURE 28 0.0003
910 EXPOSURE DURING PREGNANCY 21 0.0003
911 OCULAR HYPERAEMIA 16 0.0003
912 DRUG INEFFECTIVE 444 0.0003
913 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 67 0.0003
914 BURNING SENSATION 23 0.0003
915 INJECTION SITE MASS 12 0.0003
916 ABORTION SPONTANEOUS 13 0.0003
917 DEVICE USE ERROR 11 0.0003
918 NEOPLASM PROGRESSION 11 0.0003
919 NEOPLASM MALIGNANT 21 0.0003
920 MUCOSAL INFLAMMATION 8 0.0003
921 ACNE 23 0.0003
922 ADVERSE DRUG REACTION 27 0.0003
923 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 7 0.0003
924 AGGRESSION 15 0.0003
925 PREMATURE BABY 9 0.0003
926 DRUG EFFECT DECREASED 16 0.0003
927 DRUG WITHDRAWAL SYNDROME 26 0.0003
928 EXTRA DOSE ADMINISTERED 12 0.0003
929 BONE MARROW FAILURE 6 0.0003
930 ADVERSE EVENT 27 0.0003
931 INFLUENZA LIKE ILLNESS 24 0.0003
932 PRODUCT DOSE OMISSION 19 0.0003
933 GYNAECOMASTIA 9 0.0003
934 FEMUR FRACTURE 9 0.0003
935 THERAPEUTIC PRODUCT EFFECT DECREASED 13 0.0003
936 RHABDOMYOLYSIS 12 0.0003
937 PRODUCT QUALITY ISSUE 39 0.0003
938 DRUG-INDUCED LIVER INJURY 9 0.0003
939 FLUSHING 29 0.0003
940 THERAPEUTIC RESPONSE DECREASED 17 0.0003
941 LACTIC ACIDOSIS 9 0.0003
942 DRY SKIN 37 0.0003
943 GASTRIC CANCER 7 0.0003
944 PRODUCT COMPLAINT 7 0.0003
945 OSTEONECROSIS 9 0.0003
946 ANAPHYLACTIC SHOCK 7 0.0003
947 EXPOSURE VIA SKIN CONTACT 7 0.0003
948 LUNG NEOPLASM MALIGNANT 11 0.0003
949 DRUG DOSE OMISSION 44 0.0003
950 ALOPECIA 52 0.0003
951 INJECTION SITE RASH 8 0.0003
952 JAUNDICE 7 0.0003
953 PAIN OF SKIN 7 0.0003
954 MULTIPLE SCLEROSIS 12 0.0003
955 INJECTION SITE ERYTHEMA 30 0.0002
956 NEEDLE ISSUE 7 0.0002
957 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 17 0.0002
958 OESOPHAGEAL CARCINOMA 7 0.0002
959 DRUG EXPOSURE DURING PREGNANCY 8 0.0002
960 VAGINAL HAEMORRHAGE 10 0.0002
961 PSORIATIC ARTHROPATHY 9 0.0002
962 WITHDRAWAL SYNDROME 9 0.0002
963 INJECTION SITE BRUISING 17 0.0002
964 INJECTION SITE REACTION 14 0.0002
965 SKIN EXFOLIATION 17 0.0002
966 DEVICE ISSUE 18 0.0002
967 SKIN IRRITATION 9 0.0002
968 INCORRECT ROUTE OF DRUG ADMINISTRATION 7 0.0002
969 PRODUCT STORAGE ERROR 17 0.0002
970 DRUG EFFECT INCOMPLETE 7 0.0002
971 WRONG TECHNIQUE IN DRUG USAGE PROCESS 7 0.0002
972 C-REACTIVE PROTEIN INCREASED 7 0.0002
973 PRODUCT SUBSTITUTION ISSUE 11 0.0002
974 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
975 INJECTION SITE PAIN 54 0.0002
976 FOETAL EXPOSURE DURING PREGNANCY 14 0.0002
977 BLINDNESS 7 0.0002
978 NO ADVERSE EVENT 30 0.0002
979 INJECTION SITE PRURITUS 11 0.0002
980 DEPENDENCE 9 0.0002
981 INJECTION SITE HAEMORRHAGE 13 0.0002
982 DEVICE DISLOCATION 7 0.0002
983 MATERNAL EXPOSURE DURING PREGNANCY 14 0.0002
984 DEVICE MALFUNCTION 11 0.0002
985 BREAST CANCER 14 0.0002
986 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 7 0.0001
987 DRUG DEPENDENCE 24 0.0001
988 INJECTION SITE SWELLING 11 0.0001
989 ECZEMA 7 0.0001
990 BLADDER CANCER 7 0.0001
991 MULTIPLE SCLEROSIS RELAPSE 8 0.0001
992 ACCIDENTAL EXPOSURE TO PRODUCT 12 0.0001
993 DERMATITIS ATOPIC 6 0.0001
994 SKIN BURNING SENSATION 7 0.0001